Drug Type Synthetic peptide |
Synonyms |
Target- |
Action modulators |
Mechanism Stem cells modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Ischemic Stroke | Phase 2 | Spain | 27 Jul 2023 | |
Acute Ischemic Stroke | Phase 2 | Greece | 27 Jul 2023 | |
Acute Ischemic Stroke | Phase 2 | Germany | 27 Jul 2023 | |
Acute Ischemic Stroke | Phase 2 | United Kingdom | 27 Jul 2023 | |
Acute Ischemic Stroke | Phase 2 | Germany | 27 Jul 2023 | |
Acute Ischemic Stroke | Phase 2 | Czechia | 27 Jul 2023 | |
Acute Ischemic Stroke | Phase 2 | Australia | 27 Jul 2023 | |
Acute Ischemic Stroke | Phase 2 | South Korea | 27 Jul 2023 | |
Acute Ischemic Stroke | Phase 2 | Belgium | 27 Jul 2023 | |
Acute Ischemic Stroke | Phase 2 | Finland | 27 Jul 2023 |